Qingchang Li

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Topics

Positive Breast Cancer

Radical Prostatectomy

Top Venues

Cancer medicine

Oxidative medicine and cellular longevity

Computational and mathematical methods in medicine

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Huan Ma, Siyu Jiang, Yinan Yuan, Ji Li, Yizhuo Li, Yanping Lv, Tengjiao Du, Jingqian Guan, Xizi Jiang, Lei Tian, Qianqian Zheng, Lianhe Yang, Qingchang Li
RUNX1 promotes proliferation and migration in non-small cell lung cancer cell lines via the mTOR pathway. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (11) (2023)
Ming Cheng, Hongyi Cao, Peifeng Yao, Jingqian Guan, Peihong Wu, Hairu Ji, Siyu Jiang, Yinan Yuan, Lin Fu, Qianqian Zheng, Qingchang Li
PHF23 promotes NSCLC proliferation, metastasis, and chemoresistance via stabilization of ACTN4 and activation of the ERK pathway. Cell death & disease 14 (8) (2023)
Qianze Dong, Yan Xiu, Yang Wang, Christina Hodgson, Nick Borcherding, Craig T Jordan, Jane Buchanan, Eric B Taylor, Brett A Wagner, Mariah Leidinger, Carol J Holman, Dennis J Thiele, Sean O'Brien, Hai-Hui Xue, Jinming Zhao, Qingchang Li, Howard Meyerson, Brendan F Boyce, Chen Zhao
HSF1 is a driver of leukemia stem cell self-renewal in acute myeloid leukemia. Nature communications 13 (1) (2022)
Zifang Zou, Bo Zhang, Zhihan Li, Lei Lei, Guanghao Sun, Xizi Jiang, Jingqian Guan, Yao Zhang, Shun Xu, Qingchang Li
KBTBD7 promotes non-small cell lung carcinoma progression by enhancing ubiquitin-dependent degradation of PTEN. Cancer medicine (2022)
Bing Jiang, Qian Liu, Junda Gai, Jingqian Guan, Qingchang Li
Analysis of Adjuvant Chemotherapy on Pathological Remission of Breast Cancer. Computational and mathematical methods in medicine 2021 (2021)
Xiaodan Sun, Ji Li, Yizhuo Li, Shouhan Wang, Qingchang Li
Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2/HO-1 Pathway in Ovarian Cancer Cells. Oxidative medicine and cellular longevity 2020 (2020)
Jingqian Guan, Xizi Jiang, Junda Gai, Xiaodan Sun, Jinming Zhao, Ji Li, Yizhuo Li, Ming Cheng, Tengjiao Du, Lin Fu, Qingchang Li
Sirtuin 5 regulates the proliferation, invasion and migration of prostate cancer cells through acetyl-CoA acetyltransferase 1. Journal of cellular and molecular medicine 24 (23) (2020)
Jilin Xing, Ji Li, Lin Fu, Junda Gai, Jingqian Guan, Qingchang Li
SIRT4 enhances the sensitivity of ER-positive breast cancer to tamoxifen by inhibiting the IL-6/STAT3 signal pathway. Cancer medicine 8 (16) (2019)
Jinming Zhao, Shanshan Zhong, Xing Niu, Jiwei Jiang, Ruochen Zhang, Qingchang Li
The MHC class I-LILRB1 signalling axis as a promising target in cancer therapy. Scandinavian journal of immunology 90 (5) (2019)